Solterra Renewable Energies Ltd (TLV:SOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 385.80
-24.90 (-6.06%)
At close: Jul 31, 2025, 5:14 PM IDT
Ligand Pharmaceuticals Market Cap
TLV:SOLT has a market cap or net worth of 21.24 million as of August 1, 2025.
Market Cap
21.24M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$385.80
Market Cap Chart
Since December 2, 2024, TLV:SOLT's market cap has increased from 14.48M to 21.24M, an increase of 46.69%. That is a compound annual growth rate of 78.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 21.24M | -2.09% |
| Dec 31, 2024 | 21.69M | 49.82% |
| Dec 2, 2024 | 14.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bank Leumi le-Israel B.M. | 95.01B |
| Bank Hapoalim B.M. | 84.15B |
| Elbit Systems | 71.51B |
| Teva Pharmaceutical Industries | 65.21B |
| Mizrahi Tefahot Bank | 55.16B |
| Azrieli Group | 40.51B |
| Israel Discount Bank | 40.19B |
| NICE Ltd. | 34.57B |